This webinar is organised and fully funded by Bayer and is open to healthcare professionals with an interest in oncology only. The webinar; chaired by Susan Short (Clinical Oncologist and specialist in treating adults with primary brain tumours); will look at precision oncology in CNS; what targets to look for and when; an overview of the Brain Matrix study; molecular pathology of brain tumours; NTRK and other driver mutations in CNS disease and a data overview with case study.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Our products and services are designed to benefit people and improve their quality of life. At the same time, we aim to create value through innovation, growth and high earning power.
Our products help address some of today’s biggest challenges, including global population growth, an aging society and the need to make efficient – and, wherever possible, sustainable – use of natural resources.
